Becton, Dickinson and Company, commonly known as BD, is an American multinational medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories.

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 70,000 people in more than 50 countries throughout the world. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Life Sciences and BD Interventional. The company's customers include health care institutions, science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
BD provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.